Global Neurotrophic Keratitis Market Report 2024, with Profiles of Dompe, Oyster Point Pharma, Neuroptica, Recordati Rare Diseases, KALA BIO, ReGenTree, BRIM Biotechnology, Oculis and HLB Therapeutics Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Neurotrophic Keratitis Market Outlook 2023-2036" report has been added to ResearchAndMarkets.com's offering.The global neurotrophic keratitis...

Global $500+ Mn Neurotrophic Keratitis Markets, 2023-2028 - Rising Fungal Keratitis Cases Spur Demand for New Solutions Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Neurotrophic Keratitis Market (2023-2028) by Route of Administration, Distribution Channel, and Geography, Competitive Analysis, Impact of...

Neurotrophic Keratitis Market Report Up to 2031: Visiongain Research Inc Visiongain has published a new report on Neurotrophic Keratitis Market Report 2021-2031: Forecasts By Treatment (Drugs, Devices, and Surgical Intervention) By Stage (Stage I, Stage II, and Stage III),...